Olfactory Neuroblastoma Treated by Minimally Invasive Endoscopic Resection and Postoperative Adjuvant Radiotherapy: A Representative Case and an Updated Review of the Literature


This paper presents a case of an olfactory neuroblastoma, treated with minimally invasive endoscopic resection, followed by adjuvant radiotherapy and critically reviews the current literature with regard to diagnosis and management of such malignancies. Olfactory neuroblastoma is considered to be an uncommon malignancy of the nasal cavity. The tumor arises from the specialized sensory epithelial olfactory cells, normally situated at the upper part of the nasal cavity, including the superior nasal concha, the roof of the nose and the cribriform plate. The imaging modality of choice is computed tomography and magnetic resonance imaging. Combination of surgery and radiotherapy is considered to be the standard of care for primary site disease by the majority of researchers. Combined transfacial and neurosurgical conventional approaches are adopted in most cases, mainly due to the endocranial extension and the close anatomic relationship of esthesioneuroblastomas with the ethmoid roof and cribriform plate. However, recent literature supports that endoscopic resection correlates with similar oncologic control rates, compared with open surgery, when basic oncologic surgical principles are maintained.

Share and Cite:

G. Papacharalampous, G. Kotsis, P. Vlastarakos, E. Papadopoulou, P. Saravakos and D. Davilis, "Olfactory Neuroblastoma Treated by Minimally Invasive Endoscopic Resection and Postoperative Adjuvant Radiotherapy: A Representative Case and an Updated Review of the Literature," Journal of Cancer Therapy, Vol. 3 No. 6, 2012, pp. 1074-1079. doi: 10.4236/jct.2012.36140.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] L. Berger, R. Luc and D. Richard, “L’esthesioneuroepitheliome Olfactif,” Bulletin de l’Association Fran?aise pour l’étude du Cancer, Vol. 13, 1924, pp. 410-421.
[2] G. Broich, A. Pagliari and F. Ottaviani, “Esthesioneuroblastoma: A General Review of the Cases Published Since the Discovery of the Tumour in 1924,” Anticancer Research, Vol. 17, 1999, pp. 2683-2706.
[3] P. J. Bradley, N. S. Jones and I. Robertson, “Diagnosis and Management of Esthesioneuroblastoma,” Current Opinion in Otolaryngology & Head and Neck Surgery, Vol. 11, No. 2, 2003, pp. 112-118. doi:10.1097/00020840-200304000-00009
[4] C. W. Cummings, B. H. Haughey, J. R. Thomas, L. A. Harker and P. W. Flint, “Cummings Otolaryngology Head and Neck Surgery,” 4th Edition, Elsevier Mosby, New York, 2005.
[5] V. J. Lund, H. Stammberger, P. Nicolai, et al., “European Position Paper on Endoscopic Management of Tumours of the Nose, Paranasal Sinuses and Skull Base,” Rhinol, Vol. 1, No. 22, 2010, pp. 46-51.
[6] H. Stammberger, W. Anderhuber and C. Walch, “Possibilities and Limitations of Endoscopic Treatment of Nasal and Paranasal Sinus Malignancies,” Acta Oto-Laryngologica, Vol. 53, 1999, pp. 199-205.
[7] C. Walch, H. Stammberger and W. Anderhuber, “The Minimally Invasive Approach to Olfactory Neuroblastoma: Combined Endoscopic and Stereotactic Treatment,” Laryngoscope, Vol. 110, No. 4, 2000, pp. 635-640. doi:10.1097/00005537-200004000-00018
[8] E. Unger, K. Haselsberger and C. Walch, “Combined Endoscopic Surgery and Radiosurgery as Treatment Modality for Olfactory Neuroblastoma,” Acta Neurochirurgica, Vol. 147, No. 6, 2005, pp. 595-601. doi:10.1007/s00701-005-0521-7
[9] D. Lester and R. Thompson, “Olfactory Neuroblastoma,” Head and Neck Pathology, Vol. 3, No. 3, 2009, pp. 252-259. doi:10.1007/s12105-009-0125-2
[10] E. M. Monteiro, M. G. Lopes, E. R. Santos, et al., “Endoscopic Treatment of Esthesioneuroblastoma,” Brazilian Journal of Otorhinolaryngology, Vol. 77, No. 2, 2011, pp. 171-177.
[11] K. J. Kairemo, A. P. Jekunen and M. S. Kestila, “Imaging of Olfactory Neuroblastoma—An Analysis of 17 Cases,” Auris Nasus Larynx, Vol. 25, No. 2, 1998, pp. 173-179. doi:10.1016/S0385-8146(98)00003-0
[12] D. M. Yousem, K. K. Oguz and C. Li, “Imaging of the Olfactory System,” Seminars in Ultrasound, CT & MR, Vol. 22, No. 6, 2001, pp. 456-472. doi:10.1016/S0887-2171(01)90001-0
[13] D. Pickuth, S. H. H. Kobrunner and R. P. Spielmann, “Computed Tomography and Magnetic Resonance Imaging Features of Olfactory Neuroblastoma: An Analysis of 22 Cases,” Clinical Otolaryngology, Vol. 24, No. 5, 1999, pp. 457-461. doi:10.1046/j.1365-2273.1999.00295.x
[14] J. H. Simon, W. Zhen, T. M. McCulloch, et al., “Esthesioneuroblastoma: The University of Iowa Experience 1978-1998,” Laryngoscope, Vol. 111, No. 3, 2001, pp. 488-493. doi:10.1097/00005537-200103000-00020
[15] S. Kadish, M. Goodman and C. C. Wang, “Olfactory Neuroblastoma. A Clinical Analysis of 17 Cases,” Cancer, Vol. 37, No. 3, 1976, pp. 1571-1576. doi:10.1002/1097-0142(197603)37:3<1571::AID-CNCR2820370347>3.0.CO;2-L
[16] P. Dulguerov and T. Calcaterra, “Esthesioneuroblastoma: The UCLA Experience 1970-1990,” Laryngoscope, Vol. 102, No. 8, 1992, pp. 843-849. doi:10.1288/00005537-199208000-00001
[17] P. Dulguerov, A. S. Allal and T. C. Calcaterra, “Esthesioneuroblastoma: A Meta-Analysis and Review,” Lancet Oncology, Vol. 2, No. 11, 2001, pp. 683-690. doi:10.1016/S1470-2045(01)00558-7
[18] V. J. Hyams, “Olfactory Neuroblastoma,” In: V. Hyams, J. Batsakis and L. Michaels, Eds., Tumours of the Upper Respiratory Tract and Ear, Armed Forces Institute of Pathology, Washington, 1998.
[19] G. Gruber, K. Laedrach, B. Baumert, et al., “Esthesioneuroblastoma: Irradiation Alone and Surgery Alone Are Not Enough,” International Journal of Radiation Oncology*Biology*Physics, Vol. 54, No. 2, 2002, pp. 486-491.
[20] V. J. Lund, D. Howard, W. Wei, et al., “Olfactory Neuroblastoma: Past, Present, and Future?” Laryngoscope, Vol. 113, No. 3, 2003, pp. 502-507. doi:10.1097/00005537-200303000-00020
[21] C. C. Wang, Y. L. Chen, Y. S. Hsu, et al., “Transcranial resection of Olfactory Neuroblastoma,” Skull Base: An Interdisciplinary Approach, Vol. 15, No. 3, 2005, pp. 163-171.
[22] A. K. Devaiah and M. T. Andreoli, “Treatment of Esthesioneuroblastoma: A 16-Year Meta-Analysis of 361 Patients,” Laryngoscope, Vol. 119, No. 7, 2009, pp. 1412-1416. doi:10.1002/lary.20280
[23] P. G. Castelnuovo, G. Delu, E. Sberze, et al., “Esthesioneuroblastoma: Endonasal Endoscopic Treatment,” Skull Base: An Interdisciplinary Approach, Vol. 16, No. 1, 2006, pp. 25-30.
[24] A. Folbe, I. Herzallah, U. Duvvuri, et al., “Endoscopic Endonasal Resection of Esthesioneuroblastoma: A Multicenter Study,” American Journal of Rhinology & Allergy, Vol. 23, No. 1, 2009, pp. 91-94. doi:10.2500/ajra.2009.23.3269
[25] A. K. Devaiah, C. Larsen, O. Tawfic, et al., “Esthesioneuroblastoma: Endoscopic Nasal and Anterior Craniotomy Resection,” Laryngoscope, Vol. 113, No. 12, 2003, pp. 2086-2090. doi:10.1097/00005537-200312000-00005
[26] A. Rinaldo, A. Ferlito, A. R. Shaha, et al., “Esthesioneuroblastoma and Cervical Lymph Node Metastases: Clinical and Therapeutic Implications,” Acta Oto-Laryngologica, Vol. 122, No. 2, 2002, pp. 215-221. doi:10.1080/00016480252814261
[27] A. Ferlito, A. Rinaldo and P. H. Rhys-Evans, “Contemporary Clinical Commentary: Esthesioneuroblastoma: An Update on Management of the Neck,” Laryngoscope, Vol. 113, No. 11, 2003, pp. 1935-1938. doi:10.1097/00005537-200311000-00015
[28] M. R. Gore and A. M. Zanation, “Salvage Treatment of Late Neck Metastasis in Esthesioneuroblastoma: A Meta-Analysis,” Archives of Otolaryngology—Head & Neck Surgery, Vol. 135, No. 10, 2009, pp. 1030-1034. doi:10.1001/archoto.2009.143
[29] A. M. Zanation, A. Ferlito, A. Rinaldo, et al., “When, How and Why to Treat the Neck in Patients with Esthesioneuroblastoma: A Review,” European Archives of OtoRhino-Laryngology, Vol. 267, No. 11, 2010, pp. 1667-1671. doi:10.1007/s00405-010-1360-6
[30] R. L. Foote, A. Morita, M. J. Ebersold, et al., “Esthesioneuroblastoma: The Role of Adjuvant Radiation Therapy,” International Journal of Radiation Oncology Biology Physics, Vol. 27, No. 4, 1993, pp. 835-842. doi:10.1016/0360-3016(93)90457-7
[31] H. T. Eich, B. Hero, S. Staar, et al., “Multimodality Therapy Including Radiotherapy and Chemotherapy Improves Event-Free Survival in Stage C Esthesioneuroblastoma,” Strahlentherapie und Onkologie, Vol. 179, No. 4, 2003, pp. 233-240. doi:10.1007/s00066-003-1089-x
[32] N. J. Slevin, C. J. Irwin, S. S. Banerjee, et al., “Olfactory Neural Tumours-The Role of External Beam Radiotherapy,” Journal of Laryngology & Otology, Vol. 110, No. 11, 1996, pp. 1012-1016. doi:10.1017/S0022215100135649
[33] H. T. Eich, S. Staar, O. Micke, et al., “Radiotherapy of Esthesioneuroblastoma,” International Journal of Radiation Oncology, Biology Physics, Vol. 49, No. 1, 2001, pp. 155-160. doi:10.1016/S0360-3016(00)00811-7
[34] M. E. Platek, M. Merzianu, T. L. Mashtare, et al., “Improved Survival Following Surgery and Radiation Therapy for Olfactory Neuroblastoma: Analysis of the SEER Database,” Radiation Oncology, Vol. 25, No. 6, 2011, pp. 41. doi:10.1186/1748-717X-6-41
[35] M. E. Daly, A. M. Chen, M. K. Bucci, et al., “Intensity-Modulated Radiation Therapy for Malignancies of the Nasal Cavity and Paranasal Sinuses,” International Journal of Radiation Oncology Biology Physics, Vol. 67, No. 1, 2007, pp. 151-157. doi:10.1016/j.ijrobp.2006.07.1389
[36] H. Z. Jiang, A. L. Elaimy, G. C. Jones, et al., “Olfactory Neuroblastoma Treated by Endoscopic Surgery Followed by Combined External Beam Radiation and Gamma Knife for Optic Nerve and Chiasm Sparing: A Case Report,” Journal of Medical Case Reports, 2011, Article ID: 765645.
[37] M. E. Zafereo, S. Fakhri, R. Prayson, et al., “Esthesioneuroblastoma: 25-Year Experience at a Single Institution,” Otolaryngology—Head & Neck Surgery, Vol. 138, No. 4, 2008, pp. 452-458. doi:10.1016/j.otohns.2007.12.038
[38] R. S. Polin, J. P. Sheehan, A. G. Chenelle, et al., “The role of Preoperative Adjuvant Treatment in the Management of Esthesioneuroblastoma: The University of Virginia Experience,” Neurosurgery, Vol. 42, No. 5, 1998, pp. 1029-1037. doi:10.1097/00006123-199805000-00045
[39] J. M. Sheehan, J. P. Sheehan, J. A. Jane, et al., “Chemotherapy for Esthesioneuroblastomas,” Neurosurgery Clinics of North America, Vol. 11, No. 4, 2000, pp. 693-701.
[40] E. A. McElroy, J. C. Buckner and J. E. Lewis, “Chemotherapy for Advanced Esthesioneuroblastoma: The Mayo Clinic Experience,” Neurosurgery, Vol. 42, No. 5, 1998, pp. 1023-1028. doi:10.1097/00006123-199805000-00040
[41] S. Gupta, N. Husain and S. Sundar, “Esthesioneuroblastoma Chemotherapy and Radiotherapy for Extensive Disease: A Case Report,” World Journal of Surgical Oncology, Vol. 9, 2011, p. 118. doi:10.1186/1477-7819-9-118

Copyright © 2023 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.